Experienced in Erythema Nodosum

Dr. Margarita Fallena

Rheumatology
North Texas Center For Rheumatology
12740 Hillcrest Rd, Suite 265, 
Dallas, TX 
Accepting New Patients
Experienced in Erythema Nodosum
North Texas Center For Rheumatology
12740 Hillcrest Rd, Suite 265, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Margarita Fallena is a Rheumatologist in Dallas, Texas. Dr. Fallena is rated as an Experienced provider by MediFind in the treatment of Erythema Nodosum. Her top areas of expertise are Rheumatoid Lung Disease, Rheumatoid Pneumoconiosis, Ankylosing Spondylitis, and Axial Spondyloarthritis (AxSpA). Dr. Fallena is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in TX
Languages Spoken
English
Hebrew
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cook Children's Health Plan
  • MANAGED MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

NORTH TEXAS CENTER FOR RHEUMATOLOGY
12740 Hillcrest Rd, Suite 265, Dallas, TX 75230

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Enrollment Status: Completed
Publish Date: October 26, 2022
Intervention Type: Drug
Study Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Etanercept, Adalimumab
Study Phase: Phase 4
View 4 Less Clinical Trials

1 Total Publications

Production of autoantibodies against citrullinated antigens/peptides by human B cells.
Production of autoantibodies against citrullinated antigens/peptides by human B cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 21, 2012
Similar Doctors
Advanced in Erythema Nodosum
Dr. Richard L. Stern
Rheumatology
Advanced in Erythema Nodosum
Dr. Richard L. Stern
Rheumatology

North Texas Center For Rheumatology

12740 Hillcrest Rd, Suite 265, 
Dallas, TX 
 (0.1 miles away)
972-513-1410
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Richard Stern is a Rheumatologist in Dallas, Texas. Dr. Stern is rated as an Advanced provider by MediFind in the treatment of Erythema Nodosum. His top areas of expertise are Granulomatosis with Polyangiitis, Rheumatoid Arthritis (RA), Psoriasis, and Psoriatic Arthritis. Dr. Stern is currently accepting new patients.

Advanced in Erythema Nodosum
Dr. Kathryn H. Dao
Rheumatology
Advanced in Erythema Nodosum
Dr. Kathryn H. Dao
Rheumatology
9900 N Central Expy Ste 550, 
Dallas, TX 
 (3.9 miles away)
214-648-5295
Languages Spoken:
English
See accepted insurances

Kathryn Dao is a Rheumatologist in Dallas, Texas. Dr. Dao is rated as a Distinguished provider by MediFind in the treatment of Erythema Nodosum. Her top areas of expertise are Sjogren Syndrome, Necrotizing Vasculitis, Psoriatic Arthritis, and Rheumatoid Arthritis (RA).

Experienced in Erythema Nodosum
Dr. Imran Iqbal
Rheumatology
Experienced in Erythema Nodosum
Dr. Imran Iqbal
Rheumatology

Rheumatology Associates

8144 Walnut Hill Ln, Ste 800, 
Dallas, TX 
 (3.0 miles away)
972-449-0540
Experience:
35+ years
Languages Spoken:
English
See accepted insurances

Imran Iqbal is a Rheumatologist in Dallas, Texas. Dr. Iqbal has been practicing medicine for over 35 years and is rated as a Distinguished provider by MediFind in the treatment of Erythema Nodosum. His top areas of expertise are Rheumatoid Arthritis (RA), Psoriasis, Psoriatic Arthritis, and Fibromyalgia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fallena's expertise for a condition
ConditionClose
      View All 20 Advanced Conditions
      View All 41 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile